1199 related articles for article (PubMed ID: 32719094)
1. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
2. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
[No Abstract] [Full Text] [Related]
3. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma.
Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X
Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461
[TBL] [Abstract][Full Text] [Related]
4. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma.
Zhang F; Liu Y; Yang Y; Yang K
BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731
[TBL] [Abstract][Full Text] [Related]
6. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma.
Zhu W; Ye Z; Chen L; Liang H; Cai Q
Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154
[TBL] [Abstract][Full Text] [Related]
7.
Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a novel ferroptosis-related gene signature for predicting prognosis and immune microenvironment in head and neck squamous cell carcinoma.
He F; Chen Z; Deng W; Zhan T; Huang X; Zheng Y; Yang H
Int Immunopharmacol; 2021 Sep; 98():107789. PubMed ID: 34130150
[TBL] [Abstract][Full Text] [Related]
9. A Novel Immune-Related Prognostic Signature in Head and Neck Squamous Cell Carcinoma.
Zhang Y; Chen P; Zhou Q; Wang H; Hua Q; Wang J; Zhong H
Front Genet; 2021; 12():570336. PubMed ID: 34220923
[TBL] [Abstract][Full Text] [Related]
10. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract][Full Text] [Related]
11. Six Glycolysis-Related Genes as Prognostic Risk Markers Can Predict the Prognosis of Patients with Head and Neck Squamous Cell Carcinoma.
Chen L; He X; Yi S; Liu G; Liu Y; Ling Y
Biomed Res Int; 2021; 2021():8824195. PubMed ID: 33628816
[TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation.
Zhong Q; Zhou L; Zhu D
J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes.
Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X
Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Correlation of an Autophagy-Related Gene Signature in Patients with Head and Neck Squamous Cell Carcinoma.
Yang C; Mei H; Peng L; Jiang F; Xie B; Li J
Comput Math Methods Med; 2020; 2020():7397132. PubMed ID: 33456497
[TBL] [Abstract][Full Text] [Related]
16. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
[TBL] [Abstract][Full Text] [Related]
17. HOTTIP Functions as a Key Candidate Biomarker in Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatic Analysis.
Yin X; Yang W; Xie J; Wei Z; Tang C; Song C; Wang Y; Cai Y; Xu W; Han W
Biomed Res Int; 2019; 2019():5450617. PubMed ID: 31032351
[TBL] [Abstract][Full Text] [Related]
18. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
[TBL] [Abstract][Full Text] [Related]
19. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
20. A novel seven‑miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients.
Lu L; Wu Y; Feng M; Xue X; Fan Y
Mol Med Rep; 2019 Nov; 20(5):4340-4348. PubMed ID: 31545440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]